Click on a filter below to refine your search. Remove a filter to broaden your search.
Messages that stress the accessibility of the vaccine and include “ownership” language are most effective.
Compared with those with little to no impairment, adults with serious disability were less likely to initiate COVID-19 vaccination.
Until now, the protein-based vaccine was only approved as a two-dose primary series.
The changes include a recommendation for all adults to receive a dose of the new COVID-19 vaccine and RSV vaccination.
Primary series coverage by the end of 2022 was below the 100% target set for at-risk populations.
Updated booster doses also could prevent more than 936,000 hospitalizations and save $56 billion in six months.
More than 2 million people already had received the updated vaccines by Wednesday, according to HHS.
Experts agree that booster shots are the best defense against the omicron variant of COVID-19.
Most patients with an immediate, potentially allergic reaction to Pfizer-BioNTech or Moderna mRNA COVID-19 vaccine tolerate a second dose
When a new virus is detected spilling over from animals into people, scientists will be able to quickly manufacture the necessary prototype vaccine.